It has been shown that PD-1 expression on CD4+ effector T cells and the presence of CD4+Foxp3+ Tregs suppress anti-tumor responses (Ding et al, 2012; Mkrtichyan et al, 2012). The gene discussed is FOXP3; the disease is neoplasm.